Bicara Therapeutics Inc. Common Stock (BCAX) Insider Trading
- $34,254,000.00
- $1,076,768.59
- March 6, 2026
- Claire Mazumdar
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 6, 2026 | CEO | 3,817 | $18.75 | Sell | $71,568.75 | |
| March 5, 2026 | CEO | 1,786 | $18.74 | Sell | $33,469.64 | |
| March 4, 2026 | CFO | 2,963 | $18.25 | Sell | $54,074.75 | |
| March 4, 2026 | Insider | 16,300 | $18.52 | Sell | $301,876.00 | |
| March 4, 2026 | CEO | 2,631 | $18.73 | Sell | $49,278.63 | |
| March 3, 2026 | COO | 17,392 | $18.16 | Sell | $315,838.72 | |
| March 3, 2026 | CFO | 13,555 | $18.22 | Sell | $246,972.10 | |
| March 3, 2026 | Insider | 200 | $18.45 | Sell | $3,690.00 | |
| Sept. 17, 2024 | Major Shareholder | 70,000 | $18.00 | Buy | $1,260,000.00 | |
| Sept. 16, 2024 | Director | 1,833,000 | $18.00 | Buy | $32,994,000.00 |
Insiders are both buying and selling Bicara Therapeutics Inc. Common Stock stock.
The insider traders at Bicara Therapeutics Inc. Common Stock are: Claire Mazumdar, David Raben, Ivan Hyep, James E Flynn, Ra Capital Management, L.P., and Ryan Cohlhepp
The most active insider trader at Bicara Therapeutics Inc. Common Stock is Claire Mazumdar with 3 trades.
Ryan Cohlhepp has sold the most Bicara Therapeutics Inc. Common Stock stock with a total value of $631,677.44.
Ra Capital Management, L.P. has bought the most Bicara Therapeutics Inc. Common Stock stock with a total value of $65,988,000.00.
The most recent insider trade for Bicara Therapeutics Inc. Common Stock was on March 6, 2026.
The single biggest insider buy for Bicara Therapeutics Inc. Common Stock was from Ra Capital Management, L.P. with a total value of $32,994,000.00 on Sept. 16, 2024.
The single biggest insider sell for Bicara Therapeutics Inc. Common Stock was from Ryan Cohlhepp with a total value of $315,838.72 on March 3, 2026.